Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Arroyo

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Neurology|February 1, 2015
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosisLudwig Kappos, Matthias Mehling, Rafael Arroyo, et al.
Archives of Neurology|June 18, 2002
Active human herpesvirus 6 infection in patients with multiple sclerosisRoberto Alvarez-Lafuente, Carlos Martín-Estefanía, Virginia de Las Heras, et al.
Biomedicines|February 25, 2022
Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope ExpressionSilvia Pérez-Pérez, María Inmaculada Domínguez-Mozo, María Ángel García-Martínez, et al.
Journal of Neuroimmunology|July 10, 2007
FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?Alfonso Martínez, Ana Mas, Virginia de Las Heras, et al.
BBA Clinical|December 18, 2015
Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertionJezabel Varadé, Marta García-Montojo, Belén de la Hera, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Adherence to the Mediterranean Diet Has a Protective Role against Metabolic and DNA Damage Markers in Colorectal Cancer PatientsDelia Acevedo-León, Segundo Ángel Gómez-Abril, Lidia Monzó-Beltrán, et al.
Journal of Neuroimmunology|May 19, 2009
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal studyClara de Andrés, Carol Aristimuño, Manuel Bartolomé, et al.
Neurorehabilitation|September 14, 2013
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patientsRosa Ortiz Gutiérrez, Fernando Galán Del Río, Roberto Cano de la Cuerda, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2009
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year studyCarol Aristimuño, Clara de Andrés, Manuel Bartolomé, et al.
Scientific Reports|August 3, 2022
Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-βÚrsula Muñoz, Cristina Sebal, Esther Escudero, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Neurology|February 1, 2015
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosisLudwig Kappos, Matthias Mehling, Rafael Arroyo, et al.
Archives of Neurology|June 18, 2002
Active human herpesvirus 6 infection in patients with multiple sclerosisRoberto Alvarez-Lafuente, Carlos Martín-Estefanía, Virginia de Las Heras, et al.
Biomedicines|February 25, 2022
Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope ExpressionSilvia Pérez-Pérez, María Inmaculada Domínguez-Mozo, María Ángel García-Martínez, et al.
Journal of Neuroimmunology|July 10, 2007
FcRL3 and multiple sclerosis pathogenesis: role in autoimmunity?Alfonso Martínez, Ana Mas, Virginia de Las Heras, et al.
BBA Clinical|December 18, 2015
Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertionJezabel Varadé, Marta García-Montojo, Belén de la Hera, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Adherence to the Mediterranean Diet Has a Protective Role against Metabolic and DNA Damage Markers in Colorectal Cancer PatientsDelia Acevedo-León, Segundo Ángel Gómez-Abril, Lidia Monzó-Beltrán, et al.
Journal of Neuroimmunology|May 19, 2009
Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal studyClara de Andrés, Carol Aristimuño, Manuel Bartolomé, et al.
Neurorehabilitation|September 14, 2013
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patientsRosa Ortiz Gutiérrez, Fernando Galán Del Río, Roberto Cano de la Cuerda, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2009
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year studyCarol Aristimuño, Clara de Andrés, Manuel Bartolomé, et al.
Scientific Reports|August 3, 2022
Serum levels of IgM to phosphatidylcholine predict the response of multiple sclerosis patients to natalizumab or IFN-βÚrsula Muñoz, Cristina Sebal, Esther Escudero, et al.
Pageof 12